F A. Peel

The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: July 28, 2021

Quantitative computed tomography discriminates between postmenopausal women with low spine bone mineral density with vertebral fractures and those with low spine bone mineral density only: the SHATTER study.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: August 07, 2019

Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: August 14, 2018

Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: October 23, 2017

Vertebral fracture assessment scans enhance targeting of investigations and treatment within a fracture risk assessment pathway.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: August 07, 2012

The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis.

The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis.

Quantitative computed tomography discriminates between postmenopausal women with low spine bone mineral density with vertebral fractures and those with low spine bone mineral density only: the SHATTER study.

Quantitative computed tomography discriminates between postmenopausal women with low spine bone mineral density with vertebral fractures and those with low spine bone mineral density only: the SHATTER study.

Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis.

Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis.

Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.

Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density.

Response of bone turnover markers to raloxifene treatment in postmenopausal women with osteopenia.

Response of bone turnover markers to raloxifene treatment in postmenopausal women with osteopenia.

Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study.

Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study.

The impact of glucocorticoid therapy on trabecular bone score in older women.

The impact of glucocorticoid therapy on trabecular bone score in older women.

Vertebral fracture assessment scans enhance targeting of investigations and treatment within a fracture risk assessment pathway.

Vertebral fracture assessment scans enhance targeting of investigations and treatment within a fracture risk assessment pathway.